Authors: Kelly, DJ Gilbert, RE Cox, AJ Soulis, T Jerums, GT Cooper, ME

Citation: Dj. Kelly et al., Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy, J AM S NEPH, 12(10), 2001, pp. 2098-2107

Authors: Forbes, JM Soulis, T Thallas, V Panagiotopoulos, S Long, DM Vasan, S Wagle, D Jerums, G Cooper, ME

Citation: Jm. Forbes et al., Renoprotective effects of a novel inhibitor of advanced glycation, DIABETOLOG, 44(1), 2001, pp. 108-114

Authors: Cooper, ME Thallas, V Forbes, J Scalbert, E Sastra, S Darby, I Soulis, T

Citation: Me. Cooper et al., The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation, DIABETOLOG, 43(5), 2000, pp. 660-664

Authors: Youssef, S Nguyen, DT Soulis, T Panagiotopoulos, S Jerums, G Cooper, ME

Citation: S. Youssef et al., Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding, KIDNEY INT, 55(3), 1999, pp. 907-916

Authors: Soulis, T Sastra, S Thallas, V Mortensen, SB Wilken, M Clausen, JT Bjerrum, OJ Petersen, H Lau, J Jerums, G Boel, E Cooper, ME

Citation: T. Soulis et al., A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetes, DIABETOLOG, 42(4), 1999, pp. 472-479

Authors: Roufail, E Soulis, T Boel, E Cooper, ME Rees, S

Citation: E. Roufail et al., Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine, DIABETOLOG, 41(12), 1998, pp. 1419-1425